Primary |
Depression |
66.7% |
Hyperthyroidism |
33.3% |
|
Neutropenic Sepsis |
100.0% |
|
Secondary |
Hyperthyroidism |
24.6% |
Basedow's Disease |
14.0% |
Product Used For Unknown Indication |
12.6% |
Renal Transplant |
7.2% |
Hypertension |
5.8% |
Depression |
4.8% |
Drug Use For Unknown Indication |
4.4% |
Prophylaxis |
3.4% |
Bipolar Disorder |
2.7% |
Hypothyroidism |
2.7% |
Thrombosis Prophylaxis |
2.7% |
Atrial Fibrillation |
2.0% |
Autoimmune Thyroiditis |
2.0% |
Schizophrenia |
2.0% |
Psychotic Disorder |
1.7% |
Thyroid Function Test Abnormal |
1.7% |
Affect Lability |
1.4% |
B-cell Lymphoma |
1.4% |
Diabetes Mellitus |
1.4% |
Hepatitis C |
1.4% |
|
Iron Deficiency Anaemia |
18.6% |
Hyperthyroidism |
11.6% |
Parathyroid Tumour Benign |
8.1% |
Neutropenic Sepsis |
7.0% |
Metabolic Alkalosis |
5.8% |
Thrombocytopenia |
5.8% |
Suicidal Ideation |
4.7% |
Vanishing Bile Duct Syndrome |
4.7% |
White Blood Cell Count Abnormal |
4.7% |
Oropharyngeal Pain |
3.5% |
Thyroid Neoplasm |
3.5% |
Urinary Tract Infection |
3.5% |
Hepatic Function Abnormal |
2.3% |
Hepatic Necrosis |
2.3% |
Oedema Mouth |
2.3% |
Pneumonia |
2.3% |
Rash Generalised |
2.3% |
Respiratory Failure |
2.3% |
Thyroid Function Test Abnormal |
2.3% |
Treatment Noncompliance |
2.3% |
|
Concomitant |
Drug Use For Unknown Indication |
25.9% |
Product Used For Unknown Indication |
18.5% |
Parkinson's Disease |
12.0% |
Hyperthyroidism |
7.9% |
Hypertension |
4.3% |
Rheumatoid Arthritis |
4.2% |
Ill-defined Disorder |
4.0% |
Atrial Fibrillation |
3.3% |
Schizophrenia |
2.7% |
Diabetes Mellitus |
2.6% |
Non-small Cell Lung Cancer |
2.3% |
Coronary Artery Disease |
1.8% |
Basedow's Disease |
1.8% |
Lung Neoplasm Malignant |
1.6% |
Prophylaxis |
1.6% |
Breast Cancer |
1.3% |
Affective Disorder |
1.1% |
Chronic Myeloid Leukaemia |
1.1% |
Colon Cancer |
1.1% |
Depression |
0.9% |
|
Wrong Drug Administered |
12.0% |
Medication Error |
11.3% |
Death |
7.7% |
Hyperthyroidism |
7.7% |
Rhabdomyolysis |
7.0% |
Weight Decreased |
6.3% |
Weight Increased |
6.3% |
Vomiting |
5.6% |
Sepsis |
3.5% |
Skin Discolouration |
3.5% |
Treatment Noncompliance |
3.5% |
Cardiac Arrest |
2.8% |
Dehydration |
2.8% |
Drug Eruption |
2.8% |
Headache |
2.8% |
International Normalised Ratio Increased |
2.8% |
Myocardial Infarction |
2.8% |
Pulmonary Embolism |
2.8% |
Swelling Face |
2.8% |
Toxicity To Various Agents |
2.8% |
|
Interacting |
Hyperthyroidism |
50.0% |
Bipolar I Disorder |
25.0% |
Product Used For Unknown Indication |
25.0% |
|
Nausea |
50.0% |
Psychotic Disorder |
50.0% |
|